June 15, 2020 / 12:21 PM / 22 days ago

BRIEF-Cue Biopharma Provides Update On Ongoing Phase 1 Trial Evaluating CUE-101 In Metastatic Head And Neck Cancer

June 15 (Reuters) - Cue Biopharma Inc:

* CUE BIOPHARMA PROVIDES UPDATE ON ONGOING PHASE 1 TRIAL EVALUATING CUE-101 IN RECURRENT/METASTATIC HEAD AND NECK CANCER

* CUE BIOPHARMA INC - PATIENT ENROLLMENT AND DATA GENERATION REMAIN ON SCHEDULE FOR CUE-101 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below